Secures UL and cUL certifications for four types of low- and medium-voltage circuit breakers, reinforcing competitiveness in ...
The Office of the Prosecutor of the International Criminal Court (ICC) said on Wednesday that the disqualification of Chief Prosecutor Karim A.A. Khan KC from the case against former president Rodrigo ...
In APPLAUSE-IgAN final analysis, Fabhalta demonstrated statistically significant, clinically meaningful improvement in estimated glomerular filtration rate (eGFR) slope vs. placebo over two years1eGFR ...
Mr Eric Fan, CEO, Bridge Data Centres, said, "We are honoured to partner with EWS as their first data centre client, securing a robust and sustainable water supply for our Chonburi hyperscale campus.
Olympic weightlifting championHidilyn Diaz announced on Thursday that she will be teaching in the University of the Philippines-College of Human Kinetics (UP-CHK).
Significant progress in bulk RNA sequencing, methylation mapping, multiomics integration, and spatial analyses unlocks research previously out of reach for traditional short read platforms.Leveraging ...
DEME has taken delivery of its new wind turbine installation vessel Norse Wind at the CIMC Raffles Shipyard. Designed to install the next generation of offshore wind turbines, the vessel combines ...
October 2025 - Fleet utilisation for September 2025 was 100% and utilisation for the third quarter of 2025 was 86%.
By state, the percentage of all graduates from both two- and four-year institutions who can expect to experience a positive return on investment within 10 years ranges from a high of 82 percent in ...
JMGO unveils its latest innovation, the O2S Ultra, an intelligent ultra-short throw projector that redefines the home cinema experience.
Mark Meier, Senior Leasing & Sales Associate at Starboard CRE, completed 16 lease transactions totaling 20,000 square feet at the West Coast Life Building at 605 Market Street in San Francisco. His ...
Akeso Inc. (9926.HK) today announced that the groundbreaking results from the registrational Phase III AK112-306/HARMONi-6 study of ivonescimab have been accepted for publication in The Lancet. The ...